Suppr超能文献

肺栓塞临床高度疑似患者中D-二聚体检测的失败率:三项欧洲研究的辅助分析

Failure rate of D-dimer testing in patients with high clinical probability of pulmonary embolism: Ancillary analysis of three European studies.

作者信息

Bannelier Héloïse, Kapfer Thomas, Roussel Mélanie, Freund Yonathan, Alame Karine, Catoire Pierre, Vromant Amélie

机构信息

Emergency Department, Pitié Salpêtrière Hospital, Paris, France.

Emergency Department, Saint Joseph Hospital, Paris, France.

出版信息

Acad Emerg Med. 2025 Feb;32(2):116-122. doi: 10.1111/acem.15032. Epub 2024 Nov 1.

Abstract

BACKGROUND

In patients with a high clinical probability of pulmonary embolism (PE), the high prevalence can lower the D-dimer negative predictive value and increase the risk of diagnostic failure. It is therefore recommended that these high-risk patients should undergo chest imaging without D-dimer testing although no evidence supports this recommendation.

OBJECTIVE

The objective was to evaluate the safety of ruling out PE based on D-dimer testing among patients with a high clinical probability of PE.

METHODS

This was a post hoc analysis of three European studies (PROPER, MODIGLIANI, and TRYSPEED). Patients were included if they presented a high clinical probability of PE (according to either the Wells or the revised Geneva score) and underwent D-dimer testing. The D-dimer-based strategy ruled out PE if the D-dimer level was below the age-adjusted threshold (i.e., <500 ng/mL in patients aged less than 50 and age × 10 ng/mL in patients older than 50). The primary endpoint was a thromboembolic event in patients with negative D-dimer either at index visit or at 3-month follow-up. A Bayesian approach estimated the probability that the failure rate of the D-dimer-based strategy was below 2% given observed data.

RESULTS

Among the 12,300 patients included in the PROPER, MODIGLIANI, and TRYSPEED studies, 651 patients (median age 68 years, 60% female) had D-dimer testing and a high clinical probability of PE and were included in the study. PE prevalence was 31.3%. Seventy patients had D-dimer levels under the age-adjusted threshold, and none of them had a PE after follow-up (failure rate 0.0% [95% CI 0.0%-6.5%]). Bayesian analysis reported a credible interval of 0.0%-4.1%, with a 76.2% posterior probability of a failure rate below 2%.

CONCLUSIONS

In this study, ruling out PE in high-risk patients based on D-dimer below the age-adjusted threshold was safe, with no missed PE. However, the large CI of the primary endpoint precludes a definitive conclusion.

摘要

背景

在肺栓塞(PE)临床可能性高的患者中,高患病率会降低D - 二聚体阴性预测值并增加诊断失败风险。因此,建议这些高危患者应接受胸部影像学检查而不进行D - 二聚体检测,尽管尚无证据支持这一建议。

目的

目的是评估在PE临床可能性高的患者中基于D - 二聚体检测排除PE的安全性。

方法

这是对三项欧洲研究(PROPER、MODIGLIANI和TRYSPEED)的事后分析。如果患者呈现出PE的高临床可能性(根据Wells评分或修订的Geneva评分)并接受了D - 二聚体检测,则纳入研究。基于D - 二聚体的策略在D - 二聚体水平低于年龄调整阈值时排除PE(即,年龄小于50岁的患者中<500 ng/mL,年龄大于50岁的患者中为年龄×10 ng/mL)。主要终点是在首次就诊或3个月随访时D - 二聚体阴性患者的血栓栓塞事件。贝叶斯方法根据观察到的数据估计基于D - 二聚体的策略失败率低于2%的概率。

结果

在PROPER、MODIGLIANI和TRYSPEED研究纳入的12300例患者中,651例患者(中位年龄68岁,60%为女性)进行了D - 二聚体检测且PE临床可能性高,并被纳入研究。PE患病率为31.3%。70例患者的D - 二聚体水平低于年龄调整阈值,随访后他们均无PE(失败率0.0% [95% CI 0.0% - 6.5%])。贝叶斯分析报告可信区间为0.0% - 4.1%,失败率低于2%的后验概率为76.2%。

结论

在本研究中,基于年龄调整阈值以下的D - 二聚体排除高危患者的PE是安全的,没有漏诊PE。然而,主要终点的置信区间较大,无法得出明确结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3aa2/11816009/b6781db57724/ACEM-32-116-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验